Carsten Linnemann

3.8k total citations · 2 hit papers
21 papers, 2.5k citations indexed

About

Carsten Linnemann is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Carsten Linnemann has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Carsten Linnemann's work include CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and B-cell Immunology (6 papers). Carsten Linnemann is often cited by papers focused on CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and B-cell Immunology (6 papers). Carsten Linnemann collaborates with scholars based in Netherlands, Germany and United Kingdom. Carsten Linnemann's co-authors include Ton N. Schumacher, John B.A.G. Haanen, Gavin Bendle, Laura Bies, Sander Kelderman, Riccardo Mezzadra, Sjoerd H. van der Burg, Marit M. van Buuren, Jorg J. A. Calis and Els M.E. Verdegaal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Biotechnology.

In The Last Decade

Carsten Linnemann

20 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

2014 527 citations Carsten Linnemann, Marit M. van Buuren et al. Nature Medicine profile →
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

2018 373 citations Wouter Scheper, Sander Kelderman et al. Nature Medicine profile →

Peers

Countries citing papers authored by Carsten Linnemann

Since Specialization

Citations

This map shows the geographic impact of Carsten Linnemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Linnemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Linnemann more than expected).

Fields of papers citing papers by Carsten Linnemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Linnemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Linnemann. The network helps show where Carsten Linnemann may publish in the future.

Co-authorship network of co-authors of Carsten Linnemann

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Linnemann. A scholar is included among the top collaborators of Carsten Linnemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Linnemann. Carsten Linnemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer 2022 ·Cancer Immunology Immunotherapy ·Saskia J. Santegoets, Marij J.P. Welters, (unknown), (unknown), (unknown), Bianca Weißbrich, (unknown), Carsten Linnemann, Ton N. Schumacher, Sabina Adhikary, Gavin Bendle, Sjoerd H. van der Burg	9
2	239 Engineering of potency-enhanced TCR-edited T cells for shared neoantigen-targeted cancer immunotherapy 2022 ·Regular and Young Investigator Award Abstracts ·Lianne Kok, (unknown), Paula Kroon, (unknown), Xiangjun Kong, Carsten Linnemann, Gavin Bendle, Jeroen van Heijst	1
3	Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies 2018 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Nathan P. Croft, Anthony W. Purcell, Carsten Linnemann, (unknown), Frederick Chen, Heather M. Long, Steven P. Lee, Gavin Bendle	26
4	Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers breakdown → 2018 ·Nature Medicine ·Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi, Carsten Linnemann, Gavin Bendle, (unknown), Christian Hirt, Riccardo Mezzadra, Maarten Slagter, Krijn K. Dijkstra, Roelof J.C. Kluin, Pétur Snæbjörnsson, Katy Milne, Brad H. Nelson, Henry Zijlmans, Gemma G. Kenter, Emile E. Voest, John B.A.G. Haanen, Ton N. Schumacher	373
5	T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes 2018 ·Nature Biotechnology ·Amalie Kai Bentzen, (unknown), Kamilla Kjærgaard Jensen, Andrea Marion Marquard, Leon Eyrich Jessen, Natalie J. Miller, Candice D. Church, Rikke Lyngaa, David M. Koelle, Jürgen C. Becker, Carsten Linnemann, Ton N. Schumacher, Paolo Marcatili, Paul Nghiem, Morten Nielsen, Sine Reker Hadrup	68
6	High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma (vol 21, pg 81, 2015) 2016 ·Pure Amsterdam UMC ·Carsten Linnemann, Marit M. van Buuren, Laura Bies, Els M.E. Verdegaal, Remko Schotte, Jorg J. A. Calis, Sam Behjati, Arno Velds, Henk Hilkmann, Dris El Atmioui, Marten Visser, Michael R. Stratton, John B.A.G. Haanen, Hergen Spits, Sjoerd H. van der Burg, Ton N. Schumacher	0
7	Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules 2015 ·The Journal of Immunology ·Celia R. Berkers, Annemieke de Jong, Karianne Schuurman, Carsten Linnemann, Hugo D. Meiring, Lennert Janssen, Jacques Neefjes, Ton N. Schumacher, Boris Rodenko, Huib Ovaa	49
8	Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage 2015 ·The Journal of Immunology ·Celia R. Berkers, Annemieke de Jong, Karianne Schuurman, Carsten Linnemann, Jan A. J. Geenevasen, Ton N. Schumacher, Boris Rodenko, Huib Ovaa	24
9	Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response 2014 ·Science Translational Medicine ·Pia Kvistborg, Daisy Philips, Sander Kelderman, Lois Hageman, Christian H. Ottensmeier, Deborah Joseph-Pietras, Marij J.P. Welters, Sjoerd van der Burg, Ellen Kapiteijn, Olivier Michielin, Emanuela Romano, Carsten Linnemann, Daniel E. Speiser, Christian U. Blank, John B.A.G. Haanen, Ton N. Schumacher	288
10	Towards error-free profiling of immune repertoires 2014 ·Nature Methods ·Mikhail Shugay, Olga V. Britanova, Ekaterina M. Merzlyak, Maria A. Turchaninova, Ilgar Z. Mamedov, Timur Tuganbaev, Dmitriy A. Bolotin, Dmitriy B. Staroverov, Ekaterina V. Putintseva, Karla Plevová, Carsten Linnemann, Dmitry A. Shagin, Šárka Pospı́šilová, Sergey Lukyanov, Ton N. Schumacher, Dmitriy M. Chudakov	303
11	RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer 2014 ·Molecular Therapy ·Mario Bunse, Gavin Bendle, Carsten Linnemann, Laura Bies, Stephan Schulz, Ton N. Schumacher, Wolfgang Uckert	52
12	High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma breakdown → 2014 ·Nature Medicine ·Carsten Linnemann, Marit M. van Buuren, Laura Bies, Els M.E. Verdegaal, Remko Schotte, Jorg J. A. Calis, Sam Behjati, Arno Velds, Henk Hilkmann, Dris El Atmioui, Marten Visser, Michael R. Stratton, John B.A.G. Haanen, Hergen Spits, Sjoerd H. van der Burg, Ton N. Schumacher	527
13	Pairing of T‐cell receptor chains via emulsion PCR 2013 ·European Journal of Immunology ·Maria A. Turchaninova, Olga V. Britanova, Dmitriy A. Bolotin, Mikhail Shugay, Ekaterina V. Putintseva, Dmitriy B. Staroverov, Г. В. Шаронов, Dmitry Shcherbo, Ivan V. Zvyagin, Ilgar Z. Mamedov, Carsten Linnemann, Ton N. Schumacher, Dmitriy M. Chudakov	98
14	Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms 2013 ·Purinergic Signalling ·Anke C. Schiedel, Svenja K. Lacher, Carsten Linnemann, Percy A. Knolle, Christa E. Müller	29
15	TCR repertoires of intratumoral T‐cell subsets 2013 ·Immunological Reviews ·Carsten Linnemann, Riccardo Mezzadra, Ton N. Schumacher	51
16	Blockade of TGF-β Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer 2013 ·The Journal of Immunology ·Gavin Bendle, Carsten Linnemann, Laura Bies, Ji‐Ying Song, Ton N. Schumacher	36
17	T-Cell Receptor Gene Therapy: Critical Parameters for Clinical Success 2011 ·Journal of Investigative Dermatology ·Carsten Linnemann, Ton N. Schumacher, Gavin Bendle	31
18	Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy 2010 ·Nature Medicine ·Gavin Bendle, Carsten Linnemann, Anna I. Hooijkaas, Laura Bies, Moniek A. de Witte, Annelies Jorritsma, Andrew Kaiser, Nadine Pouw, Reno Debets, Elisa Kieback, Wolfgang Uckert, Ji‐Ying Song, John B.A.G. Haanen, Ton N. Schumacher	324
19	Adenosine regulates CD8 T‐cell priming by inhibition of membrane‐proximal T‐cell receptor signalling 2009 ·Immunology ·Carsten Linnemann, Frank A. Schildberg, Anna Schurich, Linda Diehl, Silke Hegenbarth, Elmar Endl, Svenja K. Lacher, Christa E. Müller, Jürgen Frey, Luca Simeoni, Burkhart Schraven, Dirk Stabenow, Percy A. Knolle	99
20	Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 2008 ·Proceedings of the National Academy of Sciences ·Arne Bakker, (unknown), Carsten Linnemann, Mireille Toebes, Boris Rodenko, Celia R. Berkers, Sine Reker Hadrup, Wim J.E. van Esch, Mirjam H.M. Heemskerk, Huib Ovaa, Ton N. Schumacher	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact